While reports on LIM domain kinase 1 (LIMK1) in PCa specimens are limited, it may be a promising marker, as in many other cancers are LIMK1-positive, including colorectal cancer [128], lung cancer [129], osteosarcoma [130], and breast cancer [131], which also has clinical implications. This evidence concerns the gene LIMK1 and posterior cortical atrophy.